Trademark: 90066400
Word
PATIENTS CAN'T WAIT. NEITHER CAN WE.
Status
Pending
Status Code
748
Status Date
Thursday, February 22, 2024
Serial Number
90066400
Mark Type
4000
Filing Date
Wednesday, July 22, 2020
Published for Opposition
Tuesday, December 22, 2020

Trademark Owner History
LABCORP DRUG DEVELOPMENT INC. - 1st New Owner After Publication
Covance, Inc. - Owner At Publication

Classifications
44 Medical services in the fields of pathology, pharmacology, and immunology; medical and psychological counseling; medical testing for diagnostic, treatment, or screening purposes; medical testing for forensic purposes; genetic testing for medical purposes; medical testing for diagnostic and treatment purposes; consulting services in the fields of medical testing, testing for medical forensic purposes, genetic testing for medical purposes and relating to diagnostic, prophylactic and therapeutic information in the fields of disease, medical care and healthcare; medical consulting in the field of patient management and outcomes; providing an online computer database in the fields of medical testing, testing for medical forensic purposes, genetic testing for medical purposes and relating to diagnostic, prophylactic and therapeutic information in the fields of disease, medical care, and healthcare; providing an online computer database featuring medical information in the field of patient management and outcomes; providing a website featuring information in the fields of medical testing, testing for medical forensic purposes, genetic testing for medical purposes and relating to diagnostic, prophylactic and therapeutic information in the fields of disease, medical care, and healthcare; providing a website featuring medical information in the field of patient management and outcomes
42 Scientific research and development; pharmaceutical drug development and testing services; research and development of pharmaceuticals, medical devices, biotechnology, and biochemicals; medical and scientific research, namely, designing, organizing, conducting, monitoring, and managing clinical and non-clinical trials and studies on pharmaceuticals and medical devices for others; scientific consulting services for others in the field of clinical and non-clinical trials and studies on pharmaceuticals and medical devices; collection, calibration, analysis and reporting of medical and scientific research data in connection with clinical and non-clinical trials and studies on pharmaceuticals and medical devices; scientific laboratory services; scientific laboratory services, namely, formulating and bioprocessing pharmaceuticals; operating and maintaining a biorepository for medical and scientific research purposes; scientific research and analysis in the fields of bioinformatics, biomarkers, genomics, proteomics, genotyping, and genetic profiling; custom design and development of chemical reagents and biochemical assays; medical laboratory services in the field of pathology; computer hardware and software design; design and development of software for use in conducting biological research in non-clinical pharmaceutical and medical device and development studies; providing online computer databases in the fields of research and development of pharmaceuticals, medical devices, biotechnology, and biochemicals; data mining; providing a website featuring technology enabling users to remotely track, monitor, analyze, and generate reports with information and statistics from clinical and non-clinical trials and studies on pharmaceuticals and medical devices; scientific research and analysis in the field of pharmacology; advisory services in the field of pharmaceutical drug development, namely, selecting biological research models for use in testing drugs; advisory services in the field of pharmaceutical drug development, namely, selecting biomarkers for use in testing drugs; lead candidate drug optimization services, namely, scientific research in the field of identifying compounds for drug development; providing medical and scientific information in the fields of biochemistry, pharmaceuticals and clinical trials; acting as an application service provider featuring software for use in database and record management in the fields of medical testing, testing for forensic purposes, testing for quality control purposes, genetic testing, clinical and analytical testing, disease, medical care, healthcare, pharmaceuticals, medical devices, biochemicals, and biotechnology; providing non-downloadable software through a web-based portal to collect, organize, and report medical information, medical records, and diagnostic testing records; providing a web-based portal in the fields of medical testing for scientific research purposes, testing for forensic research purposes, testing for quality control purposes, genetic testing for scientific research purposes, and medical and scientific research in the field of, disease, medical care, healthcare, pharmaceuticals, medical devices, biochemicals, and biotechnology; providing temporary use of online non-downloadable software for storing, retrieving, accessing, displaying, managing, analyzing, and reviewing information and data in the fields of medical testing, testing for forensic purposes, testing for quality control purposes, genetic testing, clinical and analytical testing, disease, medical care, healthcare, pharmaceuticals, medical devices, biochemicals, and biotechnology; electronic storage of data; consulting services in the fields of testing for drug, alcohol and DNA screening for forensic research purposes and testing for quality control purposes; providing an online computer database in the fields of testing for drug, alcohol and DNA screening for forensic research purposes and testing for quality control purposes; providing a website featuring information in the fields of testing for drug, alcohol and DNA screening for forensic research purposes and testing for quality control purposes; medical testing for quality control purposes

Trademark Events
Feb 22, 2024
Statement Of Use Processing Complete
Feb 15, 2024
Use Amendment Filed
Feb 15, 2024
Teas Statement Of Use Received
Aug 25, 2023
Notice Of Approval Of Extension Request E-Mailed
Aug 24, 2023
Sou Extension 5 Granted
Aug 15, 2023
Sou Extension 5 Filed
Aug 15, 2023
Sou Teas Extension Received
Jun 24, 2023
Corrected Noa E-Mailed
May 31, 2023
Notice Of Approval Of Extension Request E-Mailed
May 30, 2023
Sou Extension 4 Granted
Feb 16, 2023
Sou Extension 4 Filed
May 30, 2023
Divisional Processing Complete
Feb 16, 2023
Divisional Request Received
Apr 25, 2023
Case Assigned To Intent To Use Paralegal
Mar 13, 2023
Case Assigned To Intent To Use Paralegal
Feb 16, 2023
Teas Request To Divide Received
Feb 16, 2023
Sou Teas Extension Received
Sep 7, 2022
Automatic Update Of Assignment Of Ownership
Aug 17, 2022
Notice Of Approval Of Extension Request E-Mailed
Aug 15, 2022
Sou Extension 3 Granted
Aug 15, 2022
Sou Extension 3 Filed
Aug 15, 2022
Sou Teas Extension Received
Feb 18, 2022
Notice Of Approval Of Extension Request E-Mailed
Feb 16, 2022
Sou Extension 2 Granted
Feb 16, 2022
Sou Extension 2 Filed
Feb 16, 2022
Sou Teas Extension Received
Aug 18, 2021
Notice Of Approval Of Extension Request E-Mailed
Aug 16, 2021
Sou Extension 1 Granted
Aug 16, 2021
Sou Extension 1 Filed
Aug 16, 2021
Sou Teas Extension Received
Feb 16, 2021
Noa E-Mailed - Sou Required From Applicant
Dec 22, 2020
Official Gazette Publication Confirmation E-Mailed
Dec 22, 2020
Published For Opposition
Dec 2, 2020
Notification Of Notice Of Publication E-Mailed
Nov 17, 2020
Approved For Pub - Principal Register
Nov 6, 2020
Assigned To Examiner
Aug 19, 2020
New Application Office Supplied Data Entered
Jul 25, 2020
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24